# Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer

> **NCT01215500** · PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 63 (actual)

## Conditions studied

- Tumor
- Cancer
- Melanoma
- Sarcoma
- Carcinoma

## Interventions

- **RADIATION:** Hypofractionated RT

## Key facts

- **NCT ID:** NCT01215500
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01215500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01215500, "Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01215500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*